Daisuke Kaya

443 total citations
19 papers, 211 citations indexed

About

Daisuke Kaya is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Daisuke Kaya has authored 19 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Daisuke Kaya's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (4 papers) and Platelet Disorders and Treatments (2 papers). Daisuke Kaya is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (4 papers) and Platelet Disorders and Treatments (2 papers). Daisuke Kaya collaborates with scholars based in Japan. Daisuke Kaya's co-authors include Yukihisa Fujinaga, Hitoshi Yoshiji, Hideto Kawaratani, Kosuke Kaji, Tadashi Namisaki, Yuki Tsuji, Takemi Akahane, Hiroaki Takaya, Kei Moriya and Takahiro Ozutsumi and has published in prestigious journals such as International Journal of Molecular Sciences, Nutrients and World Journal of Gastroenterology.

In The Last Decade

Daisuke Kaya

18 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Kaya Japan 10 105 70 45 39 34 19 211
Julien Durand France 8 39 0.4× 18 0.3× 41 0.9× 65 1.7× 36 1.1× 14 217
Ahmet Bektaş Türkiye 10 89 0.8× 16 0.2× 24 0.5× 118 3.0× 10 0.3× 31 289
Marnie J. Wood Australia 7 71 0.7× 51 0.7× 18 0.4× 38 1.0× 3 0.1× 9 264
Koji Yamashita Japan 10 152 1.4× 119 1.7× 30 0.7× 27 0.7× 27 0.8× 40 330
Bharat Maraj United States 4 179 1.7× 89 1.3× 92 2.0× 37 0.9× 39 1.1× 7 309
Leonardo Stella Italy 8 57 0.5× 59 0.8× 33 0.7× 16 0.4× 2 0.1× 14 137
Federica Vecchio Italy 11 90 0.9× 29 0.4× 29 0.6× 83 2.1× 46 1.4× 13 298
Teija Frame Australia 5 106 1.0× 61 0.9× 52 1.2× 30 0.8× 4 0.1× 6 285
Yen‐Cheng Chiu Taiwan 13 213 2.0× 211 3.0× 40 0.9× 38 1.0× 10 0.3× 36 367
Mohamed A. Metwally Egypt 8 168 1.6× 160 2.3× 22 0.5× 33 0.8× 5 0.1× 33 288

Countries citing papers authored by Daisuke Kaya

Since Specialization
Citations

This map shows the geographic impact of Daisuke Kaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Kaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Kaya more than expected).

Fields of papers citing papers by Daisuke Kaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Kaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Kaya. The network helps show where Daisuke Kaya may publish in the future.

Co-authorship network of co-authors of Daisuke Kaya

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Kaya. A scholar is included among the top collaborators of Daisuke Kaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Kaya. Daisuke Kaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Kaya, Daisuke, et al.. (2024). Secondary Growth Hormone Deficiency That Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy. Internal Medicine. 64(3). 387–391. 1 indexed citations
3.
Moriya, Kei, et al.. (2023). SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case–Control Study. Journal of Clinical Medicine. 12(16). 5411–5411. 1 indexed citations
4.
Akahane, Takemi, Daisuke Kaya, Ryuichi Noguchi, et al.. (2021). Association between Equol Production Status and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 22(21). 11904–11904. 8 indexed citations
5.
Fujinaga, Yukihisa, Hideto Kawaratani, Daisuke Kaya, et al.. (2020). Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(15). 5589–5589. 29 indexed citations
6.
Takaya, Hiroaki, Tadashi Namisaki, Shinya Sato, et al.. (2020). Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure. Journal of Clinical Medicine. 9(5). 1467–1467. 7 indexed citations
7.
Takaya, Hiroaki, Tadashi Namisaki, Kei Moriya, et al.. (2020). Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma. World Journal of Gastroenterology. 26(45). 7232–7241. 13 indexed citations
8.
Tsuji, Yuki, Kosuke Kaji, Mitsuteru Kitade, et al.. (2020). Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. Microorganisms. 8(6). 925–925. 19 indexed citations
9.
Akahane, Takemi, Manabu Akahane, Tadashi Namisaki, et al.. (2020). Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study. Journal of Clinical Medicine. 9(6). 1635–1635. 14 indexed citations
10.
Akahane, Takemi, Tadashi Namisaki, Kosuke Kaji, et al.. (2020). Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males. Nutrients. 12(4). 1036–1036. 13 indexed citations
11.
Kaji, Kosuke, Soichiro Saikawa, Hiroaki Takaya, et al.. (2020). Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. Antibiotics. 9(4). 145–145. 35 indexed citations
12.
Kawaratani, Hideto, Yuki Tsuji, Koji Ishida, et al.. (2020). Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single‐center study. Hepatology Research. 50(9). 1101–1105. 3 indexed citations
13.
Tsuji, Yuki, Hideto Kawaratani, Koji Ishida, et al.. (2019). Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia. Digestive Diseases. 38(4). 329–334. 4 indexed citations
14.
Kaya, Daisuke, Kosuke Kaji, Yuki Tsuji, et al.. (2019). TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. Cells. 8(10). 1153–1153. 18 indexed citations
15.
Yoshikawa, Masahide, Yukiteru Ouji, Fukumi Nakamura‐Uchiyama, et al.. (2018). Ancylostoma ceylanicum, novel etiological agent for traveler’s diarrhea—report of four Japanese patients who returned from Southeast Asia and Papua New Guinea. Tropical Medicine and Health. 46(1). 6–6. 17 indexed citations
16.
Asada, Shohei, Hideto Kawaratani, Tsuyoshi Mashitani, et al.. (2017). Glycogenic Hepatopathy in Type 1 Diabetes Mellitus. Internal Medicine. 57(8). 1087–1092. 10 indexed citations
17.
Kaya, Daisuke, Masahide Yoshikawa, Toshiya Nakatani, et al.. (2016). Ancylostoma ceylanicum hookworm infection in Japanese traveler who presented chronic diarrhea after return from Lao People's Democratic Republic. Parasitology International. 65(6). 737–740. 15 indexed citations
18.
Tsukamoto, Shinji, Kanya Honoki, Akira Kido, et al.. (2015). Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner's syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus. Journal of Orthopaedic Science. 21(3). 403–406. 3 indexed citations
19.
Kawaratani, Hideto, Takuya Kubo, Daisuke Kaya, et al.. (2014). Tuberculous peritonitis during pegylated interferon plus ribavirin combination therapy in a patient with chronic hepatitis C.. PubMed. 111(12). 2337–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Durand Breakdown of academic impact, for papers by Ahmet Bektaş Breakdown of academic impact, for papers by Marnie J. Wood Breakdown of academic impact, for papers by Koji Yamashita Breakdown of academic impact, for papers by Bharat Maraj Breakdown of academic impact, for papers by Leonardo Stella Breakdown of academic impact, for papers by Federica Vecchio Breakdown of academic impact, for papers by Teija Frame Breakdown of academic impact, for papers by Yen‐Cheng Chiu Breakdown of academic impact, for papers by Mohamed A. Metwally
Rankless by CCL
2026